Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA 4.45EWJ 2.89TECK.B.TO 5.26CNQ.TO -0.07HHL.TO 0.035SYLD 1.14HAC.TO 0.14TRU -2.15
Pfizer Inc (PFE)

NYSE:PFE

Pfizer Inc (PFE)

26.17
+0.57 (2.23%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
322 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
HOLD

Pfizer Inc(PFE)

Aug 30, 2002
Fair market value is more than share price.
Photo of Ross HealyRoss HealyUnlock Rating
$33.08

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Aug 30, 2002
Now is a good time for drug stocks.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$33.08

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Aug 21, 2002
At a good level now.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$34.22

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Aug 20, 2002
Earnings growth is sustainable.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$33.69

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Aug 13, 2002
In the midst of a large merger.
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$31.78

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Aug 08, 2002
Extremely cheap. Great product line up.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$33.16

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Pfizer Inc(PFE)

Jul 24, 2002
Starting to look good at $26.
Photo of Ross HealyRoss HealyUnlock Rating
$27.89

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Jul 19, 2002
Great company. Could drop further.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$26.82

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY ON WEAKNESS

Pfizer Inc(PFE)

Jul 17, 2002
Good long term track record. Good management. Would like at a lower level.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$29.26

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jul 02, 2002
Likes the drug sector.
Photo of Brendan CaldwellBrendan CaldwellUnlock Rating
$32.80

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

Jun 06, 2002
Sector has been hit hard. At a good level. Prefers Pfizer over Merck.
Photo of John ZechnerJohn ZechnerUnlock Rating
$33.91

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

Jun 03, 2002
Photo of Andrew McCreathAndrew McCreathUnlock Rating
$33.43

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Pfizer Inc(PFE)

May 31, 2002
Maney that went in as a defensive move is now leaving. Valuation in the sector got too high.
Photo of David BurrowsDavid BurrowsUnlock Rating
$34.60

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
BUY

Pfizer Inc(PFE)

May 31, 2002
Excellent company. Should meet their growth potential this year. Great product lines.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$34.60

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Pfizer Inc(PFE)

May 27, 2002
Company has been doing well. Revenues growing @ 10%, earnings @ 20%. Trading at 19 X. Great long term.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$35.49

Stock price when the opinion was issued

$26.17

As of Jun 11, 2026. Market Open.

biotechnologypharmaceutical
Showing 721 to 735 of 801 entries
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV -2.21$161.55
WSP.TO 0.31$183.77
VRTX 9.33$445.04
OTEX.TO 0.24$30.52
CCO.TO 5.6$138.04

Today's Top Picks

NVDA 4.45$204.87
EWJ 2.89$92.18
TECK.B.T… 5.26$88.81
CNQ.TO -0.07$63.52
HHL.TO 0.035$6.945

Popular Articles

Latest Sell Signals

TD.TO 2.57$162.22
MBLY 0.44$9.58
ASAN -0.12$7.46
MODG 0.53$16.79
NVTS 1.71$22.21

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica